Publisher
Springer Science and Business Media LLC
Subject
General Immunology and Microbiology,Microbiology,Infectious Diseases
Reference123 articles.
1. Tacconelli, E. et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 18, 318–327 (2018). This WHO list prioritizes target pathogens for antibacterial drug research and discovery with a global perspective.
2. Theuretzbacher, U. et al. Analysis of the clinical antibacterial and antituberculosis pipeline. Lancet Infect. Dis. 19, e40–e50 (2019).
3. World Health Organization. 2019 antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline. https://apps.who.int/iris/bitstream/handle/10665/330420/9789240000193-eng.pdf (WHO, 2019).This WHO report presents the updated analysis of the global clinical pipeline including drugs against tuberculosis.
4. Theuretzbacher, U. Antibiotic innovation for future public health needs. Clin. Microbiol. Infect. 23, 713–717 (2017).
5. Theuretzbacher, U. Global antimicrobial resistance in Gram-negative pathogens and clinical need. Curr. Opin. Microbiol. 39, 106–112 (2017).
Cited by
238 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献